Janus Kinase (JAK) Inhibitor Therapeutic Report 2024: Strategic Evaluation of Over 50 Companies and 55+ Pipeline Drugs
15 août 2024 11h04 HE
|
Research and Markets
Dublin, Aug. 15, 2024 (GLOBE NEWSWIRE) -- The "Janus Kinase (JAK) Inhibitor - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The latest insights into the...